Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Douglas Teixeira Leffa, MD, PhD

Douglas Teixeira Leffa, MD, PhD

Dr Leffa is a psychiatry resident at the University of Pittsburgh Medical Center.

Articles by Douglas Teixeira Leffa, MD, PhD

Psychiatric Times with heart

What We Love About Psychiatry: Reflections From the Field

ByJohn J. Miller, MD,Allison S. Baker, MD,Douglas Teixeira Leffa, MD, PhD,Timothy Wilens, MD,Benjamin E. Yerys, PhD,Jennie Byrne, MD, PhD,Elysia Davis, PhD,Benjamin Hankin, PhD,Gary W. Small, MD

February 14th 2026

Adult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis

ByDouglas Teixeira Leffa, MD, PhD,Heidi Anne Duerr, MPH

January 22nd 2026

Douglas Leffa, MD, PhD, shares highlights from a poster at the APSARD conference examining severity and age of diagnosis.

Latest Updated Articles

Trending on Psychiatric Times

Improving but Not Feeling It: Anticipatory Anhedonia and Cognition

Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder

ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function

What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?

Evidence-Based Ethical Principles for Long-Acting Injectable Antipsychotic Use